Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
Paul A. Cohen(The University of Western Australia), Arjun Jeyarajah, Asma Faruqi, Martin Buck(Imperial College London), Enken Drecoll, Nichola Cope, Takahiro Ebata, Elizabeth Brown, Holger Bronger(Technical University of Munich), Helena Møgelbjerg Ditzel(Odense University Hospital), Tjalling Bosse(Leiden University Medical Center), Max Bulsara(The University of Notre Dame Australia), Ranjit Manchanda(University of London), Gustavo Rubino de Azevedo Focchi(Universidade Federal de São Paulo), Michelle Lockley(University College Hospital), Cor D. de Kroon, Rosalind Glasspool(Institut Bergonié), Brooke E. Howitt(Cancer Institute (WIA)), Simi Aggarwal, Kavita Gupta, Raji Ganesan(Birmingham Women’s and Children’s NHS Foundation Trust), Edwina Coghlan, Andrew Dean, Frediano Inzani, Steffen Böhm(University of Exeter), Eleanor C. Brockbank(Barts Health NHS Trust), Michael-John Devlin, Gian Franco Zannoni(Università Cattolica del Sacro Cuore), Michelle Samora de Almeida, Tarek Meniawy(St John of God Subiaco Hospital), Jung‐Yun Lee(Yonsei University), Stefanie Avril(Cornell University), Divya Midha(Tata Medical Center), Radhika Srinivasan(Galgotias University), Mayu Yunokawa(Japanese Foundation For Cancer Research), Naveena Singh(University of British Columbia), Rachael van der Griend(Canterbury Health Laboratories), Trupti Mandalia(Royal Devon & Exeter NHS Foundation Trust), Laura Feeney, Iain A. McNeish(Imperial College London), Aime Powell(St John of God Subiaco Hospital), Hyun Soo Kim(Pharmicell (South Korea)), Nhu D. Le(Canadian Centre for Applied Research in Cancer Control), Yun Yi Tan(Beatson West of Scotland Cancer Centre), C. Blake Gilks(Fox Chase Cancer Center), Ian Harley(Università Cattolica del Sacro Cuore), Syed Abdullah Javaid Bukhari, W. Glenn McCluggage(Belfast Health and Social Care Trust), Anna Fagotti, Colin J.R. Stewart(King Edward Memorial Hospital)
Cited by 121
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k